A quantitative study of neuropeptide immunoreactive cell bodies of primary afferent sensory neurons following rat sciatic nerve peripheral axotomy

doi:10.1016/0167-0115(91)90254-E

Regulatory Peptides

Volume 35, Issue 1, 23 July 1991, Pages 59-72

https://doi.org/10.1016/0167-0115(91)90254-E Get rights and content

Abstract

Following peripheral axotomy, fluoride resistant acid phosphatase (FRAP) and most neuropeptides are depleted in the central terminals of axotomised nerves and reduced in their corresponding cell bodies (DRG) but vasoactive intestinal polypeptide (VIP) increases. The increase in VIP probably results from a change in gene expression in other ganglion cells which do not normally express VIP. A quantitative study was performed to investigate the proportion of DRG cells immunoreactive for different peptides at increasing times after sciatic nerve section. Retrograde fluorescent neuronal labelling of sciatic nerve cell bodies by injection of fast blue into the proximal stump was combined with unlabelled antibody immunohistochemistry for CGRP and VIP. The proportion of cells immunoreactive for these peptides was quantified between two and fourteen days post-axotomy.

The number of VIP immunoreactive profiles increased significantly in the first 4 days post-axotomy, followed by a slight decrease before rising again. In contrast, the number of and CGRP-immunoreactive cell profiles declined to zero by 14 days post-axotomy. 4 days post-axotomy 50% of VIP positive cells were also immunoreactive for CGRP. There was neither colocalisation between VIP and FRAP nor between CGRP and FRAP.

It is concluded that many peptidergic DRG cell bodies switch their expression of peptide to VIP after injury, whereas non-peptide-containing subpopulations do not.

References (39)

G.P. McGregor et al.
Effect of peripheral nerve section and nerve crush on spinal cord neuropeptides in the rat: increased VIP and PHI in the dorsal horn
Neuroscience
(1984)
S.A.S. Shehab et al.
Vasoactive intestinal polypeptide (VIP) increases in the spinal cord after peripheral axotomy of the sciatic nerve originate from primary afferent neurons
Brain Res.
(1986)
T. Jessell et al.
Substance P depletion in the dorsal horn of rat spinal cord after sections of the peripheral processes of primary sensory neurons
Brain Res.
(1979)
D. Barbut et al.
Substance P in spinal cord dorsal horn decreases following peripheral nerve injury
Brain Res.
(1981)
A. Tessler et al.
Sciatic nerve transection produces death of dorsal root ganglion cells and reversible loss of substance P in spinal cord
Brain Res.
(1985)
S.A.S. Shehab et al.
The origin of the sciatic nerve and changes in neuropeptides after axotomy a double labelling study using retrograde transport of true blue and vasoactive intestinal polypeptide immunohistochemistry
Brain. Res.
(1986)
K. Fuji et al.
Vasoactive intestinal polypeptide (VIP)-containing neurons in the spinal cord of the rat and their projections
Neurosci. Lett.
(1983)
S.J. Gibson et al.
The distribution and origin of VIP in the spinal cord of six mammalian species
Peptides
(1984)
J.M. Lundberg et al.
Occurrence of vasoactive intestinal polypeptide (VIP)-like immunoreactivity in certain cholinergic neurons of the cat: evidence for combined immunohistochemistry and acetylcholinesterase staining
Neuroscience
(1979)
U. Nielsch et al.
Reciprocal regulation of tachykinin- and vasoactive intestinal polypeptide-gene expression in rat sensory neurons following cut and crush injury
Brain Res.
(1989)

M.M. Tuchscherer et al.

Immunohistochemical studies of substance P, cholecystokinin-octapeptide and somatostatin in dorsal root ganglia of the rat

Neuroscience

(1985)

H. Aldskogius et al.

Selective neuronal destruction by ricinus communis agglutinin I and its use for quantitative determination of sciatic nerve dorsal root ganglion cell numbers

Brain Res.

(1988)

Y. Lee et al.

Coexistence of calcitonin gene-related peptide and substance P-like peptide in single cells of the trigeminal ganglion of the rat: immunohistochemical analysis

Brain Res.

(1985)

C. Molander et al.

Substance P-, somatostatin- and calcitonin gene-related peptide-like immunoreactivity and fluoride resistant acid phosphatase activity in relation to retrogradely labelled cutaneous, muscular and visceral primary sensory neurons in the rat

Neurosci. Lett.

(1987)

Y. Lee et al.

Distribution of calcitonin gene-related peptide in the rat peripheral nervous system with reference to its coexistence with substance P

Neuroscience

(1985)

R.M. Lindsay et al.

Neuropeptide expression in cultures of adult sensory neurons: modulation of substance P and calcitonin gene-related peptide levels by nerve growth factor

Neuroscience

(1989)

C.J. Dalsgaard et al.

Peripheral projections and neuropeptide coexistence in a subpopulation of fluoride-resistant acid phosphatase reactive spinal primary sensory neurons

Neurosci. Lett.

(1984)

J.D. Leah et al.

Coexistence of peptide immunoreactivity in sensory neurons of the cat

Neuroscience

(1985)

P.A. Carr et al.

Calcitonin gene-related peptide in primary afferent neurons of rat: coexistence with fluoride-resistant acid phosphatase and depletion by neonatal capsaicin

Neuroscience

(1990)

Cited by (60)

The impact of short-lasting repeated vibrations on retrograde axonal transport, the expression of CGRP and parvalbumin in lower lumbar dorsal root ganglia
2011, Brain Research
Citation Excerpt :
DRG sensory neurons can synthesize a wide variety of neuropeptides which can interact under certain circumstances. It has been also shown that many peptidergic DRG sensory neurons can switch the expression of one peptide to another one after injury, whereas non-peptide-containing subpopulations do not (Doughty et al., 1991). There is a large support that PV is a marker for fast firing neurons which have a high level of activity (Carr et al., 1989; Celio, 1984).
A prolonged exposure to vibration stimuli triggers pathological changes with many later manifested symptoms. Early vibration-induced changes are still not very well explored. Therefore, short 30 min vibration period per day with frequency 60 Hz repeated for 10 days was used, and the retrograde axonal transport from the sciatic nerve, the expression of calcitonin gene-related peptide (CGRP) and parvalbumin (PV) were studied in the dorsal root ganglia (DRGs) corresponding to lower lumbar spinal levels. Repeated vibration markedly decreased (25 and 34%) the accumulation of retrogradely transported Fluorogold to spinal motor neurons, whereas a significant increase (35 and 25%) was seen in the DRG primary sensory neurons corresponding to the L4 and L5 spinal level. Immunohistochemical studies showed a significant reduction of CGRP-positive small-sized neuronal cells in both DRGs. Fluoro-Jade labeling revealed that marked loss of CGRP-imunoreactive DRG sensory neurons is not due to neuronal degeneration. CGRP protein expression determined by Western blot analysis and optical density measurement, and NGF level measured by ELISA have been decreased, markedly only at the L4 DRG. PV protein expression was not affected by short repeated vibrations. Our results indicate that (a) short-lasting repeated vibrations affect the retrograde axonal transport in the DRG sensory neurons differently than in spinal motor neurons; (b) a decreased NGF-dependent CGRP production in the DRG primary sensory neurons plays an important role in early vibration-induced pathological mechanisms.
Activin acts with nerve growth factor to regulate calcitonin gene-related peptide mRNA in sensory neurons
2007, Neuroscience
Citation Excerpt :
The addition of high levels of NGF (100 ng/ml) did not increase CGRP mRNA at 2 or 6 h (data not shown) but increases were detected at 24 h and CGRP mRNA levels continued to increase each day in this NGF concentration (Fig. 1A gray bars). While CGRP mRNA levels appear to decline with time without added NGF (Doughty et al., 1991; Shadiack et al., 2001) neuronal cell survival is known to remain high in these cultures (Omri and Meiri, 1990; Cruise, 2004), and indeed, GAPDH mRNA levels detected by real-time PCR remain similar (data not shown). From these data, we chose to examine CGRP regulation at 4 days in vitro to obtain robust and reproducible CGRP mRNA increases.
Calcitonin gene-related peptide (CGRP) increases in sensory neurons after inflammation and plays an important role in abnormal pain responses, but how this neuropeptide is regulated is not well understood. Both activin A and nerve growth factor (NGF) increase in skin after inflammation and induce CGRP in neurons in vivo and in vitro. This study was designed to understand how neurons integrate these two signals to regulate the neuropeptide important for inflammatory pain. In adult dorsal root ganglion neurons, NGF but not activin alone produced a dose-dependent increase in CGRP mRNA. When added together with NGF, activin synergistically increased CGRP mRNA, indicating that sensory neurons combine these signals. Studies were then designed to learn if that combination occurred at a common receptor or shared intracellular signals. Studies with activin IB receptor or tyrosine receptor kinase A inhibitors suggested that each ligand required its cognate receptor to stimulate the neuropeptide. Further, activin did not augment NGF-initiated intracellular mitogen-activated protein kinase signals but instead stimulated Smad phosphorylation, suggesting these ligands initiated parallel signals in the cytoplasm. Activin synergy required several NGF intracellular signals to be present. Because activin did not further stimulate, but did require NGF intracellular signals, it appears that activin and NGF converge not in receptor or cytoplasmic signals, but in transcriptional mechanisms to regulate CGRP in rat sensory neurons after inflammation.
Extracorporeal shock wave therapy improves motor dysfunction and pain originating from knee osteoarthritis in rats
2007, Osteoarthritis and Cartilage
Citation Excerpt :
A CGRP antagonist reduces the response of hyperexcitable spinal neurons to both innocuous and noxious pressure applied to the inflamed joint12. After sciatic nerve sectioning in the rat, CGRP-ir in DRG neurons was decreased13, and the rats demonstrated analgesia to heat stimuli. Furthermore, there was a significant decrease in the number of CGRP-ir DRG neurons in rofecoxib-treated rats, which was also correlated with behavioral data where hypersensitivity was significantly reduced4.
Although there have been several reports on the use of extracorporeal shock wave therapy (ESWT), the efficacy of ESWT for knee osteoarthritis (OA) has not been clarified. The aim of this study is to investigate the effect of ESWT on OA in a rat knee model.
The rats were divided into three groups: (1) control, (2) OA, and (3) ESWT (knee OA + shock wave therapy). Behavioral analysis consisted of measuring the duration of walking on a treadmill. The expression of calcitonin gene-related peptide (CGRP) in dorsal root ganglion (DRG) neurons innervating the knee using immunohistochemistry was examined in the three groups at their peak time point on the treadmill.
Walking duration was significantly extended 4, 7 and 14 days after ESWT in rats with knee OA (peak time point: 4 days), again decreasing by days 21 and 28. Immunohistochemical studies revealed that the OA group had significantly higher percentages of CGRP positive neurons in the DRG than were found in the control group. In addition, ESWT reduced the ratio of CGRP positive DRG neurons in the OA model.
The improvement in walking ability and the reduction of CGRP positive neurons in DRG indicates that ESWT is a useful treatment for knee OA.
Application of shock waves to rat skin decreases calcitonin gene-related peptide immunoreactivity in dorsal root ganglion neurons
2003, Autonomic Neuroscience: Basic and Clinical
There have been several reports on the use of extracorporeal shock waves in the treatment of pseudarthrosis, calcifying tendinitis, and tendinopathies of the elbow. However, the pathomechanism of pain relief has not been clarified. To investigate the analgesic properties of shock wave application, we analyzed changes in calcitonin gene-related peptide (CGRP)-immunoreactive (ir) dorsal root ganglion (DRG) neurons. In the nontreated group, fluorogold-labeled dorsal root ganglion neurons innervating the most middle foot pad of hind paw were distributed in the L4 and L5 dorsal root ganglia. Of these neurons, 61% were CGRP-ir. However, in the shock wave-treated group, the percentage of FG-labeled CGRP-ir DRG neurons decreased to 18%. These data show that relief of clinical pain after shock wave application may result from reduced CGRP expression in DRG neurons.
Increased expression of vasoactive intestinal polypeptide in cultured myenteric neurons from adult rat small intestine
2003, Autonomic Neuroscience: Basic and Clinical
Adult neurons possess the ability to adapt to a changing environment. Loss of target-derived neurotrophic factors due to axotomy or isolation by culturing is known to induce changes in neuropeptide expression in several types of peripheral neurons. The aim of the present study was to investigate changes in the expression of vasoactive intestinal polypeptide (VIP) and nitric oxide synthase (NOS) in cultured myenteric ganglia and dissociated neurons. Myenteric ganglia and neurons from rat small intestine were dissociated and cultured for up to 21 days. Immunocytochemistry was used to determine the total number of neurons and the proportions of subpopulations containing VIP or NOS or both in preparations of whole mounts (controls used to determine the conditions in vivo), myenteric ganglion culture and dissociated myenteric neuronal culture. In situ hybridization was used to determine changes in the expressions of NOS and VIP mRNA. The relative number of VIP-expressing neurons increased significantly during culturing. The percentage of all neurons expressing VIP was 3.6±0.3% in whole mounts, 22–24% in cultured myenteric ganglia, and up to 35% in cultured dissociated neurons. NOS-expressing neurons constituted approximately 30–40% of all neurons in whole mounts as well as in cultured ganglia or dissociated neurons. A dramatic increase in NOS/VIP-containing neurons were detected in cultured neurons irrespective of whether they were arranged in ganglia or dissociated, as compared to whole mount preparations. This suggests that the NOS-containing neurons are the ones that increase their VIP expression. The induced expression of VIP in cultured adult myenteric neurons indicates that VIP is important for neuronal adaptation, maintenance and survival.
Complex array of cytokines released by vasoactive intestinal peptide
2003, Neuropeptides
A complex mixture of five cytokines has been shown to be released by vasoactive intestinal peptide (VIP). Cytokines were measured in paired samples of culture medium and astroglial cytosol by capillary electrophoresis. This is the first description of VIP-mediated release for TNF-α, IL-3, G-CSF and M-CSF from astrocyte cultures. Kinetic studies after VIP treatment demonstrated a gradual but incomplete depletion of cytosolic cytokine levels, with differences observed among the cytokines. Significant increases in release were apparent within 15–30 min for all cytokines. As the recognized VIP receptors (VPAC1 and VPAC2) are linked to adenylate cyclase and also interact with pituitary adenylate cyclase activating polypeptide-38 (PACAP-38), both this homologous peptide and 8-bromo cAMP were investigated and compared to VIP-mediated release. Treatment with 1 mM 8-bromo cAMP produced cytokine release similar in amount to 0.1 nM PACAP-38, but significantly less (<50%) in comparison to 0.1 nM VIP. PACAP-38 and VIP exhibited similar EC₅₀’s for the release of G-CSF and TNF-α; however, the maximal release was 4–6 times greater for VIP than for PACAP-38. This similarity in potency suggested a VPAC-like receptor; however, the greater efficacy for VIP in comparison to PACAP-38, combined with a lack of cAMP production at subnanomolar concentrations of VIP, suggested a mechanism not currently associated with VPAC receptors. For M-CSF, IL-3 and IL-6, the EC₅₀’s of VIP were 3–30 times more potent than those of PACAP-38 in producing release. These studies suggested that multiple mechanisms mediate cytokine release in astrocytes: (1) a low efficacy release produced by PACAP-38 that is cAMP-mediated and (2) a high efficacy, VIP-preferring mechanism that was not linked to cAMP. In summary, subnanomolar concentrations of VIP released a complex array of cytokines from astrocytes that may contribute to the mitogenic and neurotrophic properties of this neuropeptide in the central nervous system.

View all citing articles on Scopus

^∗: Present address: I.C.I. Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.

^∗∗: Present address: Department of Psychology, University of Sheffield, Western Bank, Sheffield S10 2TN, U.K.

View full text

A quantitative study of neuropeptide immunoreactive cell bodies of primary afferent sensory neurons following rat sciatic nerve peripheral axotomy

Abstract

Neuroscience

Brain Res.

Brain Res.

Brain Res.

Brain Res.

Brain. Res.

Neurosci. Lett.

Peptides

Neuroscience

Brain Res.

Neuroscience

Brain Res.

Brain Res.

Neurosci. Lett.

Neuroscience

Neuroscience

Neurosci. Lett.

Neuroscience

Neuroscience